
北美生物制药管市场预测至 2028 年 - COVID-19 影响以及按类型(塑料、金属和硅胶)和应用(制药、医疗器械、研发等)进行的区域分析
No. of Pages: 116 | Report Code: TIPRE00024059 | Category: Life Sciences
No. of Pages: 116 | Report Code: TIPRE00024059 | Category: Life Sciences
生物制药管材采用挤出工艺生产,广泛应用于药物输送系统、饲管等蠕动泵。这些产品具有卓越的热学、机械和化学特性,可用于各种微创应用,包括支架输送系统、心血管导管和泌尿外科检索设备。此外,这些还用于麻醉和呼吸设备、静脉注射和生物制药实验室设备。
北美生物制药管材市场预计将从2021年的18.037亿美元增至2028年的30.9082亿美元;预计2021年至2028年复合年增长率为8.0%。市场的增长归因于一些关键驱动因素,例如世界老年人口的增加以及对微创手术的需求不断增长。然而,政府对生物制药应用的严格监管框架预计将限制预测期内的市场增长。
预期寿命的延长导致世界老年人口的增加。老年人口的增加导致老年疾病的增加,从而对诊断设备和药物输送系统产生了更大的需求。它还增加了需要导尿的泌尿系统疾病的发生率。医疗专业人员还鼓励自行导尿,以减少住院费用和住院时间,并避免医疗保健相关感染 (HAI) 的风险。衰老也是导致慢性疾病增加的一个主要因素,这可能导致需要进入重症监护病房进行干预。因此,老年人口的快速增长与对医疗设备不断增长的需求成正比,这些设备包括管道、药物输送、透析和心脏搭桥、蠕动泵以及无菌灌装和分配系统,从而推动了生物制药管道系统的采用。此外,近年来微创外科手术越来越受欢迎,因为它具有切口小、患者康复更快、给患者带来的不适更少等优点。关节炎、癌症和心血管疾病的患病率不断上升,所有这些疾病都需要广泛的手术治疗,这增加了对微创手术的需求。因此,对导管和生物制药管材等组件的需求巨大。此外,生物制药管道系统价格合理,有助于节省时间。例如,使用导管进行心导管插入术和尿导管插入术可显着缩短医疗或外科手术所需的时间。因此,对微创医疗手术的需求不断增长以及对提高这些手术效率的关注在推动生物制药管材的需求方面发挥着重要作用。
北美地区因 COVID-19 大流行的爆发而受到严重影响。北美市场参与者正在采取措施抗击疫情。例如,美国生物制药管材公司圣戈班生命科学公司确定了可以对抗 COVID-19 的产品,并给予了优先考虑。该公司优先交付COVID-19产品订单,包括用于开发新疫苗和疗法的一次性组件以及用于救生医疗设备(例如呼吸机和输液泵)的组件;因此,对包含管材的医疗设备的需求不断增长。因此,北美对包含管材的医疗器械不断增长的需求可能会推动生物制药管材市场的增长。
根据类型,北美生物制药管道市场分为塑料、金属和硅胶。有机硅细分市场在 2021 年占据最大的市场份额,预计在预测期内将实现最高的复合年增长率。
根据应用情况,北美生物制药管材市场分为制药、医疗器械、研发等。制药领域在 2021 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。
p>
一些相关的主要和次要来源这份关于北美生物制药管材市场的报告由美国疾病控制与预防中心 (CDC)、经济合作与发展组织 (OECD) 以及食品和药物管理局 (FDA) 共同发布。
Strategic insights for North America Biopharmaceutical Tubing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,803.70 Million |
Market Size by 2028 | US$ 3,090.82 Million |
Global CAGR (2021 - 2028) | 8.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Biopharmaceutical Tubing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Biopharmaceutical Tubing Market is valued at US$ 1,803.70 Million in 2021, it is projected to reach US$ 3,090.82 Million by 2028.
As per our report North America Biopharmaceutical Tubing Market, the market size is valued at US$ 1,803.70 Million in 2021, projecting it to reach US$ 3,090.82 Million by 2028. This translates to a CAGR of approximately 8.0% during the forecast period.
The North America Biopharmaceutical Tubing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Biopharmaceutical Tubing Market report:
The North America Biopharmaceutical Tubing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Biopharmaceutical Tubing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Biopharmaceutical Tubing Market value chain can benefit from the information contained in a comprehensive market report.